Multitarget Stool DNA Testing Outperforms FIT/FOBT for Completed Follow-up Colonoscopy in CRC-Vulnerable Populations
May 05, 2025

DDW 2025. Follow-up colonoscopy after a positive stool-based test was superior among adults aged 45-49 and across diverse populations whose original test was mt-sDNA.

Tirzepatide Switch Outperforms Dulaglutide Dose Escalation in T2D: Daily Dose
May 05, 2025

Your daily dose of the clinical news you may have missed.

Marschall Runge, MD PhD, Shares Thoughts on the Trajectory of Measles in the US
May 05, 2025

Measles, declared eradicated in the US 25years ago, has infected 900 Americans and is responsible for 3 deaths of children younger than age 5. How did we get here?

Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows
May 02, 2025

A simple RNA-based blood test can identify the risk of hypertensive disorders in pregnancy months before symptoms appear, researchers reported.

PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD
May 02, 2025

ACP 2025: Dr Fakorede outlines PAD risk amplifiers, polyvascular disease connections, and when to screen using ABI, TBI, or exercise testing in high-risk patients.

AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma
May 02, 2025

The KALOS and LOGOS registration trials in patients with uncontrolled asthma compared the triple fixed dose BGF with dual combination therapy.

The Role of Extended HPV Genotyping In Managing High Risk Patients
May 02, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds
May 02, 2025

Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.

"It Costs Too Much," Americans Say About Skipping Necessary Medical Care: Survey Findings
May 02, 2025

Affordability is pushing an increase in deferred care — even among the insured —and physicians are feeling the effects.

Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose
May 02, 2025

Your daily dose of the clinical news you may have missed.